Achieve Life Sciences ACHV Contingent Consideration Liability (Non-Current)
Contingent Consideration Liability (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's contingent consideration liability (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's contingent consideration liability (non-current)?
- Achieve Life Sciences (ACHV) reported contingent consideration liability (non-current) of $1.27M in Q1 2026.
- How has Achieve Life Sciences's contingent consideration liability (non-current) changed year-over-year?
- Achieve Life Sciences's contingent consideration liability (non-current) increased by 2.6% year-over-year, from $1.24M to $1.27M.
- What is the long-term trend for Achieve Life Sciences's contingent consideration liability (non-current)?
- Over 2 years (2023 to 2025), Achieve Life Sciences's contingent consideration liability (non-current) has grown at a -100.0% compound annual growth rate (CAGR), from $528K to $0.
- What does contingent consideration liability (non-current) mean?
- This represents the estimated fair value of future payments owed as part of a business combination, contingent upon the achievement of specific milestones or performance targets. It reflects the long-term financial commitment associated with past acquisitions or licensing agreements. Monitoring this liability is essential for understanding the company's future cash outflows and the valuation of its acquired intangible assets.